A pharmacological study on the role of nitric oxide in the pathogenesis of experimental allergic encephalomyelitis

Inflammation Research

Volumn 45, Issue 10, 1996, Pages 524-529

  Scott, G S ^a   Williams, K I ^a   Bolton, C ^a  

^a University of Bath ^*  (United Kingdom)

Author keywords

Experimental allergic encephalomyelitis; Nitric oxide; Pharmacological manipulation

Indexed keywords

7 NITROINDAZOLE; AMINOGUANIDINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DATA ANALYSIS; DISEASE COURSE; MALE; NEUROLOGIC DISEASE; NONHUMAN; PATHOGENESIS; RAT;

ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITES; RATS; RATS, INBRED LEW; WEIGHT LOSS;

EID: 0029827401     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02311090     Document Type: Article

References (44)

1. Dijkstra CD, De Groot CJA, Huitinga I. The role of macrophages in demyelination. J Neuroimmunol 1992;40:183-9.
2. Montgomery DL. Astrocytes: Form, functions, and roles in disease. Vet Pathol 1994;31:145-67.
3. Hartung H-P, Jung S, Stoll G, Zielasek J, Schmidt B, Archelos JJ. Inflammatory mediators in demyelinating disorders of the CNS and PNS. J Neuroimmunol 1992;40:197-210.
4. Vladutiu AO. Role of nitric oxide in autoimmunity. Clin Immunol Immunopathol 1995;76:1-11.
5. Förstermann U, Closs EI, Pollock JS, Nakane M, Schwarz P, Gath I, et al. Nitric oxide synthase isozymes Characterization, purification, molecular cloning, and functions. Hypertension 1994;23:1121-31.
6. Schmidt HHHW, Lohmann SM, Walter U. The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochim Biophys Acta 1993;1178:153-75.
7. Morris SM, Billiar TR. New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol 1994;266:E829-39.
8. Murphy S, Simmons ML, Agullo L, Garcia A, Feinstein DL, Galea E, et al. Synthesis of nitric oxide in CNS glial cells. TINS 1993;16:323-8.
9. Xie Q, Nathan C. The high-output nitric pathway: role and regulation. J Leuk Biol 1994;56:576-82.
10. Moncada S, Higgs A. Mechanisms of disease: The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-12.
11. Vincent SR. Nitric oxide: A radical neurotransmitter in the central nervous system. Prog Neurobiol 1994;42:129-60.
12. Faraci FM, Brian JE. Nitric oxide and the cerebral circulation. Stroke 1994;25:692-703.
13. Merrill JE, Ignarro LJ, Sherman MP, Melinek J, Lane TE. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 1993;151:2132-41.
14. Koprowski H, Zheng YM, Heber-Katz E, Fraser N, Rorke L, Fu ZF, et al. In vivo expression of inducible nitric oxide synthase in experimentally induced neurological diseases. Proc Natl Acad Sci USA 1993;90:3024-7.
15. Brosnan CF, Battistini L, Raine CS, Dickson DW, Casadevall A, Lees SC. Reactive nitrogen intermediates in human neuropathology: An overview. Dev Neurosci 1994;10:152-61.
16. MacMicking JD, Willenborg DO, Weidemann MJ, Rockett KA, Cowden WB. Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalitogenic T cells. J Exp Med 1992;176:303-7.
17. Scott GS, Lees P, Williams KI, Bolton C. The role of nitric oxide (NO) in neurovascular disruption during the development of experimental allergic encephalomyelitis (EAE) in Lewis rats. J Physiol 1994;480:P19.
18. Cross AH, Misko TP, Rin RF, Hicket WF, Trotter JL, Tilton RG. Aminoguanidine an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J Clin Invest 1994;93:2684-90.
19. Zielasek J, Jung S, Gold R, Liew FY, Toyka KV, Hartung HP. Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis. J Neuroimmunol 1995;58:81-8.
20. Bolton C, Flower RJ. The effects of the anti-glucocorticoid RU 38486 on steroid-mediated suppression of experimental allergic encephalomyelitis (EAE) in the Lewis rat. Life Sci 1989;45:97-104.
21. Babbedge RC, Bland-Ward PA, Hart SL, Moore PK. Inhibition of rat cerebellar nitric oxide synthase by 7-nitroindazole and related substituted indazoles. Br J Pharmacol 1993;110:225-8.
22. Förstermann U, Gorsky LD, Pollock JS, Schmidt HHHW, Heller M, Murad F. Regional distribution of FDRF NO synthesizing enzymes (s) in rat brain. Biochim Biophys Res Commun 1990;168:727-32.
23. 15N] nitrate in biological fluids. Anal Biochem 1982;126:131-8.
24. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
25. Bolton C, Gordon D, Turk JL. Prostaglandin and thromboxane levels in central nervous system tissues from rats during the induction and development of experimental allergic encephalomyelitis (EAE). Immunopharmacology 1984;7:101-7.
26. Paul C, Bolton C. Inhibition of blood-brain barrier disruption in experimental allergic encephalomyelitis by short-term therapy with dexamethasone or cyclosporin A. Int J Immunopharmacol 1995;17:497-503.
27. Bö L, Dawson TM, Wesselingh S, Mörk S, Choi S, Kong PA, et al. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol 1994;36:778-86.
28. Hooper DC, Ohnishi ST, Kean R, Numagami Y, Dietzschold B, Koprowski H. Local nitric oxide production in viral and autoimmune disease of the central nervous system. Proc Natl Acad Sci USA 1995;92:5312-6.
29. Okuda Y, Nakatsuji Y, Fujimura H, Esumi H, Ogura T, Sakoda S. Expression of the inducible nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis. J Neuroimmunol 1995;62:103-12.
30. Lin RT, Lin TS, Tilton RG, Cross AH. Nitric oxide localized to spinal cords of mice with experimental autoimmune encephalomyelitis: an electron paramagnetic resonance study. J Exp Med 1993;178:643-8.
31. Ludowyk PA, Hughes W, Hugh A, Willenborg DO, Rockett KA, Parish CR. Astrocytic hypertrophy: An important pathological feature of chronic experimental autoimmune encephalitis in aged rats. J Neuroimmunol 1993;48:121-34.
32. Skaper SD, Facci L, Leon A. Inflammatory mediator stimulation of astrocytes and meningeal fibroblasts induces neuronal degeneration via the nitridergic pathway. J Neurochem 1995;64:266-76.
33. Ruuls SR, Van der Linden S, Sontrop K, Huitinga I, Dijkstra CD. Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors. Clin Exp Immunol 1996;103:467-74.
34. Ovadia H, Mizrachi-Koll R, Lehmann D, Abramsky O. Experimental allergic encephalomyelitis is suppressed with a nitric oxide synthase inhibitor. J Neuroimmunol 1994;54:188.
35. Ruuls SR, Van der Linden S, Huitinga I, Dijkstra CD. Nitric oxide as immunesuppressor in experimental allergic encephalomyelitis. J Neuroimmunol 1994;54:193.
36. Bolton C. Recent advances in the pharmacological control of experimental allergic encephalomyelitis (EAE) and the implications for multiple sclerosis (MS) treatment. Multiple Sclerosis: Clin Lan Res 1995;1:143-9.
37. Griffiths MJD, Messent M, MacAllister RJ, Evans TW. Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br J Pharmacol 1993;110:963-8.
38. Rees DD, Palmer RMJ, Schuls R, Hodson HF, Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 1990;101:746-52.
39. Moore PK, Babbedge RC, Wallace P, Gaffen ZA, Hart SL. 7-nitroindazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure. Br J Pharmacol 1993;108:296-7.
40. Leonard JP, Mackenzie FJ, Patel HA, Cuzner ML. Splenic noradrenergic and adrenocortical responses during preclinical and clinical stages of adoptively transferred experimental autoimmune encephalomyelitis (EAE). J Neuroimmunol 1990;26:183-6.
41. Hewson AK, Smith T, Leonard JP, Cuzner ML. Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790. Inflamm Res 1995;44:345-9.
42. Levine S, Strebel R, Wenk EJ, Harman PJ. Suppression of experimental allergic encephalomylitis by stress. Proc Soc Exp Biol Med 1962;109:294-8.
43. Macphee IAM, Antoni FA, Mason DW. Spontaneous-recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune-system by endogenous adrenal corticosteroids. J Exp Med 1989;169:431-45.
44. Weicker H, Werle E. Interaction between hormones and the immune system. Int J Sports Med 1991;12:830-7.